Skip to main content

Arthritis Research & Therapy

Ausgabe Sonderheft 3/2004

Global Arthritis Research Network (GARN): 4th World Congress on Arthritis in Montreal

Inhalt (104 Artikel)

Oral presentation

Health needs assessment of musculoskeletal conditions: an international bone and joint burden of disease study

N Khaltaev, B Pfleger, AD Woolf, K Åkesson, JM Hazes, D Symmons

Oral presentation

Genetics of osteoarthritis

J Loughlin, A Ferreira, B Dowling, L Southam, Z Mustafa, T Forster, K Chapman

Oral presentation

Genome-wide single nucleotide polymorphism analyses on rheumatoid arthritis

K Yamamoto, A Suzuki, S Tokuhiro, Y Kochi, R Yamada

Oral presentation

Rheumatoid arthritis: a heterogeneous disease evaluated by DNA-microarray technology

PV Kasperkovitz, T Timmer, T Smeets, PP Tak, TWJ Huizinga, GS Firestein, F Rustenburg, TCTM van der Pouw Kraan, M Fero, CL Verweij

Oral presentation

Hyper-ERAD: a novel pathomechanism for rheumatoid arthritis

T Nakajima, N Yagishita, S Yamasaki, K Tsuchimochi, T Amano, A Fukamizu, I Maruyama, K Nishioka

Oral presentation

Is leptin the link between obesity and osteoarthritis?

P Pottie, N Presle, H Dumond, B Terlain, D Mainard, D Leuille, P Netter

Oral presentation

Regulation of eicosanoid synthesis by leptin

P Mancuso, HH Mehta, C Canetti, M Peters-Golden, BJ Roessler, LJ Crofford

Oral presentation

Transcriptional regulation of the mPGES-1 gene in primary cultured articular chondrocytes

P Bausero, C Salvat, V Meynier de Salinelles, A Pigenet, M Raymondjean, F Berenbaum

Oral presentation

Regulation of neutrophil trafficking by the lipid mediators of inflammation

S Marleau, J Lefebvre, H El Iman, C Bélanger, P Borgeat

Oral presentation

The nonsense allele oblivious reveals a sensor of di-acylglycerides acting in conjunction with TLR2 and TLR6

K Hoebe, K Tabeta, P Georgel, X Du, S Mudd, S Sovath, L Shamel, T Hartung, Ul Zähringer, B Beutler

Oral presentation

An apoptotic signaling pathway activated by Nod1

J da Silva Correia, Y Miranda, N Austin-Brown, J Mathison, J Han, RJ Ulevitch

Oral presentation

A proinflammatory chemokine, CCL3, sensitizes the heat-gated and capsaicin-gated ion channel, TRPV1

N Zhang, S Inan, A Cowan, AD Guler, R Sun, J Wang, TJ Rogers, M Caterina, JJ Oppenheim

Oral presentation

A genetic analysis of lupus

AN Theofilopoulos

Oral presentation

Cellular-based immune modulation in arthritis

REM Toes, J van Bilsen, H van Dongen, L Lard, EIH van der Voort, D Elferink, A Bakker, A Miltenburg, FC Breedveld, TH Huizinga, RRP de Vries

Oral presentation

Regulating innate immune response cytokines in synovitis

IB McInnes, D Xu, JA Gracie, X Wei, FY Liew

Oral presentation

Galectin-3 in osteoarthritis: from a protective to a destructive role

C Boileau, J Martel-Pelletier, M Guévremont, J-P Pelletier, F Poirier, P Reboul

Oral presentation

Angiogenesis and arthritis: a potential therapeutic target?

J Grosjean, B Sivakumar, E Paleolog

Oral presentation

The αvβ3 integrin as a therapeutic target for inhibition of bone resorption

SJ Dixon, J Bashutski, M-L Rütz, HA Goldberg, SM Sims, A Gramoun, S Shorey, M Manolson, JN Heersche, H Zhang, J Suzich, S-Y Mao

Oral presentation

Overview: imaging, biomarkers and arthritis

C Peterfy

Oral presentation

Imaging and osteoarthritis

F Cicuttini, A Wluka

Oral presentation

A 2-year evaluation of disease progression by quantitative magnetic resonance imaging in a large primary osteoarthritic patient population

J-P Raynauld, J Martel-Pelletier, M-J Berthiaume, G Beaudoin, F Labonté, DA Bloch, D Choquette, B Haraoui, RD Altman, M Hochberg, J Beary, G Cline, J Meyer, DJ Valent, J-P Pelletier

Oral presentation

Markers in rheumatoid arthritis

FC Breedveld

Oral presentation

Autoantibodies and cognitive impairment in systemic lupus erythematosus

C Kowal, L DeGiorgio, P Huerta, H Hetherington, B Volpe, B Diamond

Oral presentation

Mechanisms of autoimmunity in mice lacking the mer membrane tyrosine kinase

PL Cohen, Y Du, V Abraham, M Waldman, A Choudhury, A Vogelgesang, G Wittenburg

Oral presentation

Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone

H Carlsten, H Forsblad D'Elia, M Erlandsson, U Islander

Oral presentation

Adverse effects of rheumatoid arthritis on bone remodeling

SR Goldring, EM Gravallese

Oral presentation

Mechanisms of pain in arthritis

H-G Schaible

Oral presentation

Innate immunity and Toll-like receptors

LAJ O'Neill

Oral presentation

Regulation of B-cell tolerance by complement C4

M Alimzhanov, T Imanishi-Kari, MC Carroll

Oral presentation

Complement and autoimmunity: new insights into old questions

VM Holers, N Banda, DM Kraus, KA Kuhn, M Muggli, JM Thurman, WP Arend

Oral presentation

Insights into systemic lupus erythematosus pathogenesis through blood global gene expression analysis

V Pascual, L Bennett, F Allantaz, E Arce, J Banchereau

Poster presentation

Molecular regulation of gene expression in chondrocytes by inflammatory mediators

MB Goldring, H Peng, K Ijiri, T Libermann, P Oettgen

Poster presentation

Endothelin-1 induces extracellular matrix degradation via matrix metalloproteinases induction in human osteosarcoma cells

M Felx, F Shipkolye, M Isler, J Doyon, A Moreau, F Moldovan

Poster presentation

Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production

CA Manacu, J Martel-Pelletier, M Roy-Beaudry, J-P Pelletier, JC Fernandes, F Shipkolye, F Moldovan

Poster presentation

Intracellular IL-1Ra exhibits unique antiinflammatory properties

WP Arend, N Banda, M Muggli, D Sheppard, C Guthridge, K Santopietro, D Bech-Otschir, W Dubiel

Poster presentation

Quantitative measurements of articular cartilage by magnetic resonance imaging

LD Hall, J Burge, S Evans, R Poole

Poster presentation

Elevated C-reactive protein levels in osteoarthritis are associated with local joint inflammation

AD Pearle, CR Scanzello, SS George, L Mandl, EF DiCarlo, MK Crow, TP Sculco

Poster presentation

Protective role of interferon gamma in murine antigen-induced arthritis

M Hückel, I Irmler, J Simon, A Radbruch, A Scheffold, R Bräuer

Poster presentation

Regulatory role of C5a anaphylatoxin on the Fcγ Rs effector system in immune complex-induced diseases

RE Schmidt, J Skokowa, SR Ali, W Kumar, N Shushakova, JE Gessner

Poster presentation

The potential role of adiponectin in driving arthritis

U Müller-Ladner, A Ehling, E Neumann, IH Tarner, H Herfarth, J Grifka, J Schölmerich, S Gay, A Schäffler

Poster presentation

Leptin induces production of eicosanoids and proinflammatory cytokines in human synovial fibroblasts

LJ Crofford, HH Mehta, BJ Roessler, P Mancuso

Poster presentation

Activation of peroxisome proliferator-activated receptor γ inhibits IL-1β-induced mPGES-1 expression in human synovial fibroblasts by interfering with Egr-1

S Cheng, H Afif, J Martel-Pelletier, J-P Pelletier, X Li, K Farrajota, M Lavigne, H Fahmi

Poster presentation

15-Deoxy-Δ12,14-prostaglandin J2inhibits IL-1β-induced cyclooxygenase-2 expression in human synovial fibroblasts through a histone deacetylase-independent mechanism

K Farrajota, H Afif, J Martel-Pelletier, J-P Pelletier, X Li, S Cheng, M Lavigne, H Fahmi

Poster presentation

A critical role for leukotriene B4 in K/BxN serum transfer arthritis pathogenesis

M Chen, BK Lam, KF Austen, Y Kanaoka, DM Lee

Poster presentation

Clusterin, a potential pathophysiological actor in rheumatoid arthritis

V Devauchelle, M Breban, M Dougados, C Fournier, G Chiocchia

Poster presentation

An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus

RA Eisenberg, S Khan, J Stansberry, D Tsai, S Kolasinski, E Rieder, B Kotzin, RJ Looney, C Strieber, D Albert

Poster presentation

Lymphoid chemokine expression in Sjogren's syndrome: relationship with the lymphoid organization of the periductal inflammatory aggregates

F Barone, M Bombardieri, MC Blades, A Manzo, P Morgan, S Challacombe, G Valesini, C Pitzalis

Poster presentation

The role of TLR4 and neutrophil expression in infection-triggered arthritis

X Zhang, M Glogauer, F Zhu, T Kim, B Chiu, RD Inman

Poster presentation

Advanced glycation endproducts in the development of osteoarthritis

J DeGroot, RA Bank, JWJ Bijlsma, JM TeKoppele, N Verzijl, FPJG Lafeber

Poster presentation

New emerging roles of transcription factor Pitx1 and Reg growth factors in osteoarthritis pathogenesis

A Moreau, DS Wang, S Jacques, C Chassaing, V Landreville, J Martel-Pelletier, J Fernandes

Poster presentation

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation

B Görtz, S Hayer, J Zwerina, M Tohidast-Akrad, K Redlich, G Steiner, JS Smolen, G Schett

Poster presentation

Abnormal collagen type I production in osteoarthritic subchondral bone is associated with a reduced capacity of osteoblasts to mineralize in vitro

I Aubry, A Delalandre, JC Fernandes, J Martel-Pelletier, J-P Pelletier, D Lajeunesse

Poster presentation

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis

K Redlich, P Herrak, B Görtz, S Hayer, E Reiter, J Gasser, H Bergmeister, G Kollias, JS Smolen, G Schett

Poster presentation

Cytokine networks in human severe combined immunodeficiency: a model for regulating T-cell homeostasis

DD Patel, V Tchernev, R Wolfinger, S Lezhnin, E Satyaraj, SA Kingsmore, RH Buckley

Poster presentation

Regulation of T-cell differentiation by IL-4Rα-chain single nucleotide polymorphisms

I Prots, A Skapenko, S Mattyasovszky, CL Yoné, JR Kalden, H Schulze-Koops

Poster presentation

GATA-3 in human T helper cell type 2 development

A Skapenko, J Leipe, U Niesner, K Devriendt, R Beetz, A Radbruch, JR Kalden, PE Lipsky, H Schulze-Koops

Poster presentation

P-selectin, an important mediator of angiogenesis in females: the role of estradiol

AE Koch, OV Volpert, MV Volin, JM Woods, JH Ruth, CC Park, MA Amin

Poster presentation

Synovial cadherin-11

D Lee, H Kiener, S Agarwal, J Higgins, M Brenner

Poster presentation

Effects of hypoxia on protein and gene expression in fibroblast-like synoviocytes

H El-Gabalawy, K Dasuri, C Hitchon, K Wong, G Ma, M Koshiji, S Der, O Wilkins, E Huang, J Wilkins

Poster presentation

Magnetic resonance imaging, X-ray and dual X-ray absorptiometry techniques for assessment and monitoring of knee osteoarthritis

P Boulos, D Inglis, KA Beattie, G Ioannidis, CL Gordon, J Duryea, CE Webber, JD Adachi

Poster presentation

Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes

H Afif, X Li, J Martel-Pelletier, J-P Pelletier, H Fahmi

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

CKD bei Diabetes: Neuheiten und Zukunftsaussichten

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Jeder Mensch mit Diabetes muss auf eine chronische Nierenerkrankung gescreent werden – diese neue Empfehlung spricht die KDIGO aus. Die Therapie erfolgt individuell und je nach Szenario mit verschiedenen Substanzklassen. Künftig kommt wahrscheinlich, neben RAS-Hemmung, SGLT2-Inhibition und nsMRA, eine vierte Therapiesäule hinzu.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.